Insurance claims rose 61% from 2007 - 2015 for oral cancer. Males (74%) were 3 times more prevalent than females (26%) according to FAIR Health's repository of over 21 billion claims.
Your duty: Be sure every patient has an oral cancer screening at their recall at least once a year. Use an adjunctive product like the new ViziLite® Pro for detection of epithelial dysplasia that may be invisible to the naked eye.
